Has Judy Moore received payments from drug or device companies?

Yes. Drug and device makers reported $2,982 in general payments to Judy Moore across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Judy Moore did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Judy Moore come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Judy Moore

Pediatrics · Florence, ALNPI 1477658425

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 33.9% of the total. Among pediatrics clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,982in general payments, 2019–2025

Across 117 payments — averaging $25.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
GSK$410
Corium, LLC$344
Merck$312
Sanofi-aventis U.S. LLC$134
Dexcom, Inc.$125
plus $646 from 12 others

What the payments were for

Food & beverage$2,96299%
Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	11	$1,011
GSK	14	$410
Corium, LLC	42	$344
Merck	18	$312
Sanofi-aventis U.S. LLC	8	$134
Dexcom, Inc.	1	$125
Kowa Pharmaceuticals America, Inc.	1	$114
Johnson & Johnson	1	$100
Supernus Pharmaceuticals, Inc.	5	$92
AbbVie	1	$68
Sanofi Pasteur Inc.	3	$65
Lilly USA, LLC	1	$36
Pfizer	2	$34
Tris Pharma Inc	2	$34
Takeda Pharmaceuticals U.S.A., Inc.	2	$31
Genentech USA, Inc.	2	$30
Adlon Therapeutics L.p.	2	$27
Neos Therapeutics, LP	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,982 in reported general payments places this provider in the 95th percentile of 908 pediatrics providers in Alabama.

See all pediatrics providers in Alabama →

Other pediatrics in Florence

Tamera Coyne-BeasleyBirmingham$154K
Linda HammettBirmingham$123K
Darby McElderryBirmingham$111K
James WileyMobile$44K
Audrey LloydBirmingham$40K
Suresh BoppanaBirmingham$31K
Sula GillespieBirmingham$19K
Brian StansellBirmingham$19K
Leslie PittsBirmingham$10K
Yolanda WheelerBirmingham$10K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →